1-3 of 3
Ken Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Trial of IPI-504, a Novel, Water-Soluble Hsp90 Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Sundar Jagannath, MD, David Siegel, MD, Paul Richardson, MD, Amitabha Mazumder, MD, Jens Sydor, PhD, Jill Goddard, John Walker, Jon Patterson, Emmanuel Normant, PhD, Jeffrey Tong, PhD, Vito Palombella, PhD, Ken Anderson, MD, Julian Adams, PhD, David Grayzel, MD
Journal: Blood
Blood (2005) 106 (11): 2560.
https://doi.org/10.1182/blood.V106.11.2560.2560
Published: 2005
Journal Articles

Dendritic Cell Myeloma Fusions Stimulate Anti-Tumor Immunity: Results from Pre-Clinical Studies and a Clinical Trial.

David Avigan, MD, Baldev Vasir, PhD, Zekui Wu, MD, Lynne Uhl, MD, Therese Desliva, Jacalyn Rosenblatt, MD, James D. Levine, MD, Robin Joyce, MD, Ken Miller, MD, Nikhil Munshi, MD, Paul Richardson, MD, Joann Proper, RN, Nancy Gillombardo, NP, Patty Forino, RN, Marisa Villaroel, Ken Anderson, MD, Donald Kufe, MD
Journal: Blood
Blood (2004) 104 (11): 751.
https://doi.org/10.1182/blood.V104.11.751.751
Published: 2004
Journal Articles

Multicenter Phase III Trial to Evaluate CD34 + Selected Versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma

Robert Vescio, Gary Schiller, A. Keith Stewart, Oscar Ballester, Stephen Noga, Hope Rugo, Cesar Freytes, Edward Stadtmauer, Stefano Tarantolo, Firoozeh Sahebi, Pat Stiff, Jacinta Meharchard, Robert Schlossman, Randy Brown, Heather Tully, Mark Benyunes, Cindy Jacobs, Ronald Berenson, John DiPersio, Ken Anderson, James Berenson
Journal: Blood
Blood (1999) 93 (6): 1858–1868.
https://doi.org/10.1182/blood.V93.6.1858.406k06_1858_1868
Published: 1999